Amgen Inc. (BVMF:AMGN34)

Amgen Statistics

Total Valuation

Amgen has a market cap or net worth of BRL 1.08 trillion. The enterprise value is 1.32 trillion.

Market Cap	1.08T
Enterprise Value	1.32T

Important Dates

The last earnings date was Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	Nov 19, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.19%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	0.15%
Owned by Institutions (%)	80.67%
Float	537.12M

Valuation Ratios

The trailing PE ratio is 25.43 and the forward PE ratio is 17.11.

PE Ratio	25.43
Forward PE	17.11
PS Ratio	5.34
PB Ratio	22.65
P/TBV Ratio	n/a
P/FCF Ratio	24.21
P/OCF Ratio	19.69
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.79, with an EV/FCF ratio of 29.53.

EV / Earnings	31.02
EV / Sales	6.87
EV / EBITDA	14.79
EV / EBIT	21.22
EV / FCF	29.53

Financial Position

The company has a current ratio of 1.14, with a Debt / Equity ratio of 6.31.

Current Ratio	1.14
Quick Ratio	0.73
Debt / Equity	6.31
Debt / EBITDA	3.20
Debt / FCF	6.74
Interest Coverage	4.32

Financial Efficiency

Return on equity (ROE) is 106.10% and return on invested capital (ROIC) is 18.77%.

Return on Equity (ROE)	106.10%
Return on Assets (ROA)	8.15%
Return on Invested Capital (ROIC)	18.77%
Return on Capital Employed (ROCE)	18.28%
Weighted Average Cost of Capital (WACC)	6.30%
Revenue Per Employee	7.23M
Profits Per Employee	1.52M
Employee Count	28,000
Asset Turnover	0.40
Inventory Turnover	1.62

Taxes

In the past 12 months, Amgen has paid 6.97 billion in taxes.

Income Tax	6.97B
Effective Tax Rate	14.09%

Stock Price Statistics

The stock price has increased by +9.90% in the last 52 weeks. The beta is 0.47, so Amgen's price volatility has been lower than the market average.

Beta (5Y)	0.47
52-Week Price Change	+9.90%
50-Day Moving Average	64.29
200-Day Moving Average	59.61
Relative Strength Index (RSI)	63.91
Average Volume (20 Days)	1,097

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.74

Income Statement

In the last 12 months, Amgen had revenue of BRL 202.42 billion and earned 42.47 billion in profits. Earnings per share was 78.38.

Revenue	202.42B
Gross Profit	143.29B
Operating Income	65.53B
Pretax Income	49.44B
Net Income	42.47B
EBITDA	93.99B
EBIT	65.53B
Earnings Per Share (EPS)	78.38

Balance Sheet

The company has 50.28 billion in cash and 300.76 billion in debt, with a net cash position of -250.48 billion.

Cash & Cash Equivalents	50.28B
Total Debt	300.76B
Net Cash	-250.48B
Net Cash Per Share	n/a
Equity (Book Value)	47.69B
Book Value Per Share	88.48
Working Capital	19.65B

Cash Flow

In the last 12 months, operating cash flow was 54.85 billion and capital expenditures -10.23 billion, giving a free cash flow of 44.61 billion.

Operating Cash Flow	54.85B
Capital Expenditures	-10.23B
Free Cash Flow	44.61B
FCF Per Share	n/a

Margins

Gross margin is 70.78%, with operating and profit margins of 32.37% and 20.98%.

Gross Margin	70.78%
Operating Margin	32.37%
Pretax Margin	24.42%
Profit Margin	20.98%
EBITDA Margin	46.43%
EBIT Margin	32.37%
FCF Margin	22.04%

Dividends & Yields

This stock pays an annual dividend of 1.27, which amounts to a dividend yield of 1.81%.

Dividend Per Share	1.27
Dividend Yield	1.81%
Dividend Growth (YoY)	6.16%
Years of Dividend Growth	12
Payout Ratio	1.62%
Buyback Yield	-0.19%
Shareholder Yield	1.63%
Earnings Yield	3.93%
FCF Yield	4.13%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 29, 2020. It was a forward split with a ratio of 28.

Last Split Date	Oct 29, 2020
Split Type	Forward
Split Ratio	28

Scores

Altman Z-Score	n/a
Piotroski F-Score	7